Assembly Actions - Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 08, 2020 | referred to health |
Jun 10, 2019 | referred to health |
Archive: Last Bill Status - In Assembly Committee
- Introduced
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
Your Voice
Actions
Co-Sponsors
Anthony D'Urso
Inez E. Dickens
Rebecca Seawright
William Colton
Multi-Sponsors
Sandy Galef
John Salka
A8253 (ACTIVE) - Details
A8253 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8253 2019-2020 Regular Sessions I N A S S E M B L Y June 10, 2019 ___________ Introduced by M. of A. D. ROSENTHAL -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to requiring certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 277-a to read as follows: § 277-A. NOTIFICATION OF PRESCRIPTION DRUG PRICE INCREASES BY MANUFAC- TURERS. 1. THIS SECTION SHALL APPLY TO A MANUFACTURER OF A PRESCRIPTION DRUG THAT IS PURCHASED OR REIMBURSED BY ANY OF THE FOLLOWING: (A) AN INSURANCE COMPANY AUTHORIZED IN THIS STATE TO WRITE ACCIDENT AND HEALTH INSURANCE, A COMPANY ORGANIZED PURSUANT TO ARTICLE FORTY- THREE OF THE INSURANCE LAW, A MUNICIPAL COOPERATIVE HEALTH BENEFIT PLAN ESTABLISHED PURSUANT TO ARTICLE FORTY-SEVEN OF THE INSURANCE LAW, AN ORGANIZATION CERTIFIED PURSUANT TO ARTICLE FORTY-FOUR OF THIS CHAPTER, AN INSTITUTION OF HIGHER EDUCATION CERTIFIED PURSUANT TO SECTION ONE THOUSAND ONE HUNDRED TWENTY-FOUR OF THE INSURANCE LAW, OR THE NEW YORK STATE HEALTH INSURANCE PLAN ESTABLISHED PURSUANT TO ARTICLE ELEVEN OF THE CIVIL SERVICE LAW; OR (B) A PHARMACY BENEFIT MANAGER, INCLUDING AN ENTITY THAT DIRECTLY OR THROUGH AN INTERMEDIARY, MANAGES THE PRESCRIPTION DRUG COVERAGE PROVIDED BY A HEALTH INSURER UNDER A CONTRACT OR POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE OR A HEALTH PLAN SUBJECT TO SECTION THREE HUNDRED SIXTY-FOUR-J OF THE SOCIAL SERVICES LAW, INCLUDING THE PROCESSING AND PAYMENT OF CLAIMS FOR PRESCRIPTION DRUGS, THE PERFORMANCE OF DRUG UTILI- ZATION REVIEW, THE PROCESSING OF DRUG PRIOR AUTHORIZATION REQUESTS, THE ADJUDICATION OF APPEALS OR GRIEVANCES RELATED TO PRESCRIPTION DRUG EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11426-01-9